Mehr »
Mittwoch, 23.05.2018 Börsentäglich über 12.000 News von 579 internationalen Medien



24 h / 7 T
7 Tage



24 h / 7 T
7 Tage








Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Ad hoc-Mitteilungen
12.02.2016 | 23:11
(13 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

DUBLIN, Feb. 12, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/wcrtxc/fertility_market) has announced the addition of the "Fertility Market in the US 2016-2020" report to their offering.


The fertility services market in the US is expected to grow at a CAGR of 4.07% during the period 2016-2020.

Vendors undergo M&A to expand their geographical presence, enhance their product portfolio, and attain profit margins. M&A allows vendors to gain proprietary technologies and innovative products of the acquired company. Small vendors undergo M&A to broaden their network and expand people's access to their new products.

According to the report, the fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.

Further, the report states that high cost of fertility treatment hinders the market growth.

Key questions answered in this report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key vendors:

  • Cellcura
  • CooperSurgical
  • Intramed
  • Ferring Pharmaceuticals
  • Merck

Other prominent vendors:

  • Abbott Laboratories
  • AbbVie
  • Actavis
  • Apricus Biosciences
  • AstraZeneca
  • Auxogyn
  • Bristol-Myers Squibb
  • Elelixis Diagnostics
  • Eli Lilly
  • EMD Serono
  • IKS International
  • In Vitro Care
  • Invo Bioscience
  • Irvine Scientific
  • IVFtech Aps
  • Life Global
  • Medical Electronic Systems
  • Meditex
  • Novartis
  • Ovascience
  • Pantec Biosolutions
  • Pfizer
  • Sanofi
  • Vivus
  • Xytex Cryo International

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Regulatory scenario in the US

PART 06: Market landscape

PART 07: Infertility: An overview

PART 08: Stages of fertility treatment

PART 09: Cost analysis of ART

PART 10: Market segmentation by type

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/wcrtxc/fertility_market

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

© 2016 PR Newswire